摘要 |
<p>The present invention concerns SF-25 monoclonal antibodies, especially chimeric antibodies, and derivatives and fragments thereof, having specificity to the SF-25 antigen of human tumor cells, methods of their production, pharmaceutical compositions containing them, and uses therefor.</p> |